Journal of Hematology and Oncology Research

Journal of Hematology and Oncology Research

Journal of Hematology and Oncology Research (JHOR) is a peer-reviewed scientific journal that publishes research on all aspects of hematology and oncology. The journal covers a wide range of topics, including blood disorders, cancer research, clinical trials, translational research, precision medicine, and novel therapies. In addition, the JHOR publishes articles on molecular biology, immunology, epidemiology, and health outcomes research. The JHOR is committed to advancing the understanding of hematologic and oncologic disorders.

Note: An Article Processing Charge (APC) is levied to authors to make a research work available open access in Journal of Hematology and Oncology Research.

Submit Manuscript

Journal metrics

Short code

JHOR

ISSN

2372-6601

Average Processing Time

14 days

Acceptance rate

43%

Submission to first decision

12 days

Acceptance to publication

2 days

Impact Factor

6.047

Our Specialties

Journal of Hematology and Oncology Research is a comprehensive, peer-reviewed journal that helps disseminate original research work, having a unique aspect of covering many areas which contributes to providing an awareness of research studies of scientists around the globe.

Constant Updating

Journal of Hematology and Oncology Research is committed to publishing the latest and most relevant scientific research in Gynecologic Oncology, Radiation Oncology, Oral Oncology, Molecular Oncology, Cellular Oncology, Pediatric Hematology, and Pediatric Oncology fields. Authors feedback is essential in helping us to remain at the forefront of knowledge innovation and to continue providing with the best possible service.

Aims and Scope

Simple Manuscript Submission form: Submit a research within few minutes and avail the user-friendly services provided by JHOR. Authors can use the Manuscript Zone Portal or Straightforward Manuscript Submission Form or conveniently send articles via email.

Manuscript Submission

Advanced Online Editorial Manager
High Quality Peer review

Rigorous Peer Review Process of JHOR: Peer review is a most essential process that involves subjecting research articles to the scrutiny of experts in the same field. This process helps to ensure that the research is accurate, reliable, and of the highest quality. JHOR team of experienced editors and reviewers work tirelessly to ensure that every article published in the journal undergoes a rigorous peer review process.

Peer Review

Published Articles: Each published article in the journal is assigned a DOI (Digital Object Identifier), ensuring its permanent and unique identification. This allows for easy and reliable citation and referencing in academic and scientific literature. This not only enhances the accessibility and visibility of the articles but also amplifies their impact and reach within the scientific community and beyond.

Archives

Easy-to-Use Search Functionalities
Article Email Facility

Journal of Hematology and Oncology Research levies Article Processing Charges (APCs) on authors upon acceptance of their articles for publication. The purpose of these charges is to cover the costs incurred in the publishing process, which encompass, but are not restricted to, editing, production, peer review, website hosting, and online dissemination of articles that are free from plagiarism.

Article Processing Charges

Journal of Hematology and Oncology Research is a comprehensive and peer-reviewed publication that serves to disseminate original research work. JHOR has a unique aspect of covering a wide range of areas, which contributes significantly to raising awareness of research studies conducted by scientists worldwide. The articles published in this journal will be promoted in various indexing and databases, further enhancing their visibility and impact.

Indexing

SEO

Editorial Board

Journal of Hematology and Oncology Research- Cell Proliferation

Hassan Rafieemehr

Department of Medical Laboratory Sciences, Faculty of Paramedicine, Hamadan Univ...

View Profile
Hematology and Oncology Research-Chronic myelogenous Leukemia (CML)
Stem cell biology
-Andreas Petzer, Prof., MD

Andreas Petzer, Prof., MD

Linz, Austria

View Profile
Hematology and Oncology Research-Oncology
-Fernando Luiz Affonso Fonseca

Fernando Luiz Affonso Fonseca

Artur Riedel, 275, Diadema 09972-270 Brazil

View Profile
Hematology and Oncology Research-Oncology-Wala Ben Kridis

Wala Ben Kridis

Habib Bourguiba Hospital

View Profile

Latest Articles

Hematology and Oncology Research

Understanding Inherited Bleeding Disorders: Genetic Mutations in Blood Coagulation Factors and Regulatory Proteins

Published on 01-08-2024
Read the full article

Hematology and Oncology Research

Hodgkin's Lymphoma In Low-Income Countries: Experience Of Togo

Published on 04-03-2024
Read the full article
Diamond-Blackfan anemia

Hematology and Oncology Research

Prolonged survival of Diamond-Blackfan anemia and RPS19 mutation: an observation in Togo

Published on 13-04-2023
Read the full article
Non-communicable diseases

Hematology and Oncology Research

Retracted :

Published on 29-03-2023
Read the full article

Journals By Subject

Life Sciences
Medical Sciences
SUBMIT MANUSCRIPT NOW